Phase Ib trial of HLA-DQ2 peptide vaccine for coeliac disease.
Phase of Trial: Phase I
Latest Information Update: 24 May 2016
At a glance
- Drugs HLA DQ2 peptide vaccine (Primary)
- Indications Coeliac disease
- Focus Adverse reactions
- Sponsors ImmusanT
- 04 Sep 2012 Planned study phase changed from IIa to Ib, as reported in an Immusan media release.
- 04 Sep 2012 Status changed from planning to recruiting.
- 16 Mar 2011 New trial record